Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli
Top Cited Papers
Open Access
- 12 September 2005
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 95 (2) , 437-445
- https://doi.org/10.1111/j.1471-4159.2005.03380.x
Abstract
The cannabinoid system is known to be important in neuronal regulation, but is also capable of modulating immune function. Although the CNS resident microglial cells have been shown to express the CB2 subtype of cannabinoid receptor during non-immune-mediated pathological conditions, little is known about the expression of the cannabinoid system during immune-mediated CNS pathology. To examine this question, we measured CB2 receptor mRNA expression in the CNS of mice with experimental autoimmune encephalomyelitis (EAE) and, by real-time PCR, found a 100-fold increase in CB2 receptor mRNA expression during EAE onset. We next determined whether microglial cells specifically express the CB2 receptor during EAE, and found that activated microglial cells expressed 10-fold more CB2 receptor than microglia in the resting state. To determine the signals required for the up-regulation of the CB2 receptor, we cultured microglial cells with combinations of γ-interferon (IFN-γ) and granulocyte) macrophage-colony stimulating factor (GM-CSF), which both promote microglial cell activation and are expressed in the CNS during EAE, and found that they synergized, resulting in an eight to 10-fold increase in the CB2 receptor. We found no difference in the amount of the CB2 receptor ligand, 2-arachidonylglycerol (2-AG), in the spinal cord during EAE. These data demonstrate that microglial cell activation is accompanied by CB2 receptor up-regulation, suggesting that this receptor plays an important role in microglial cell function in the CNS during autoimmune-induced inflammation.Keywords
This publication has 56 references indexed in Scilit:
- Microglial cell activation and proliferation precedes the onset of CNS autoimmunityJournal of Neuroscience Research, 2005
- The endogenous cannabinoid 2‐arachidonoyl glycerol as in vivo chemoattractant for dendritic cells and adjuvant for Th1 response to a soluble proteinThe FASEB Journal, 2004
- Endocannabinoids accumulate in spinal cord of SOD1G93A transgenic miceJournal of Neurochemistry, 2004
- Cannabinoids in Multiple SclerosisDrugs, 2004
- Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain modelsEuropean Journal of Neuroscience, 2003
- Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significanceProstaglandins, Leukotrienes & Essential Fatty Acids, 2002
- Endocannabinoids in the immune system and cancerProstaglandins, Leukotrienes & Essential Fatty Acids, 2002
- Endocannabinoids control spasticity in a multiple sclerosis modelThe FASEB Journal, 2000
- Molecular characterization of a peripheral receptor for cannabinoidsNature, 1993
- Structure of a cannabinoid receptor and functional expression of the cloned cDNANature, 1990